메뉴 건너뛰기




Volumn 21, Issue 4, 2011, Pages 480-482

Hyperammonemic encephalopathy related to valproate, phenobarbital, and topiramate synergism

Author keywords

Hyperammonemic encephalopathy; Phenobarbital; Topiramate; Valproic acid

Indexed keywords

AMMONIA; LAMOTRIGINE; PHENOBARBITAL; PHENYTOIN; TOPIRAMATE; VALPROIC ACID;

EID: 80051473634     PISSN: 15255050     EISSN: 15255069     Source Type: Journal    
DOI: 10.1016/j.yebeh.2011.05.006     Document Type: Article
Times cited : (20)

References (16)
  • 1
    • 33947228816 scopus 로고    scopus 로고
    • The SANAD study of effectiveness of valproate, lamotrigine or topiramate for generalised and unclassificable epilepsy: an unblinded randomised controlled trial
    • Marson A.G., Al-Kharusi A.M., Alwaid M., et al. The SANAD study of effectiveness of valproate, lamotrigine or topiramate for generalised and unclassificable epilepsy: an unblinded randomised controlled trial. Lancet 2007, 369:1016-1026.
    • (2007) Lancet , vol.369 , pp. 1016-1026
    • Marson, A.G.1    Al-Kharusi, A.M.2    Alwaid, M.3
  • 2
    • 1942520331 scopus 로고    scopus 로고
    • Drug induced encephalopathy in six epileptic patients: topiramate? valproate? Or both?
    • Latour P., Biraben A., Polard E., et al. Drug induced encephalopathy in six epileptic patients: topiramate? valproate? Or both?. Hum Psychopharmacol Clin Exp 2004, 19:193-203.
    • (2004) Hum Psychopharmacol Clin Exp , vol.19 , pp. 193-203
    • Latour, P.1    Biraben, A.2    Polard, E.3
  • 3
    • 0033985895 scopus 로고    scopus 로고
    • Valproate-induced hyperammonemic encephalopathy in the presence of topiramate
    • Hamer H.M., Knake S., Schomburg U., Rosenow F. Valproate-induced hyperammonemic encephalopathy in the presence of topiramate. Neurology 2000, 54:230-232.
    • (2000) Neurology , vol.54 , pp. 230-232
    • Hamer, H.M.1    Knake, S.2    Schomburg, U.3    Rosenow, F.4
  • 4
    • 34248664095 scopus 로고    scopus 로고
    • Different clinical manifestations of hyperammonemic encephalopathy
    • Gomceli Y.B., Kutlu G., Cavdar L., Sanivar F., Inan L.E. Different clinical manifestations of hyperammonemic encephalopathy. Epilepsy Behav 2007, 10:583-587.
    • (2007) Epilepsy Behav , vol.10 , pp. 583-587
    • Gomceli, Y.B.1    Kutlu, G.2    Cavdar, L.3    Sanivar, F.4    Inan, L.E.5
  • 5
    • 0021038592 scopus 로고
    • Sodium valproate associated with phenobarbital: effects on ammonia metabolism in humans
    • Warter J.M., Marescaux C., Brandt C., et al. Sodium valproate associated with phenobarbital: effects on ammonia metabolism in humans. Epilepsia 1983, 24:628-633.
    • (1983) Epilepsia , vol.24 , pp. 628-633
    • Warter, J.M.1    Marescaux, C.2    Brandt, C.3
  • 6
    • 45749150011 scopus 로고    scopus 로고
    • Antiepileptic drugs: best practice guidelines for therapeutic drug monitoring-a position paper by the Subcommission on Therapeutic Drug Monitoring, ILAE Commission on Therapeutic Strategies
    • Patsalos P.N., Berry D.J., Bourgeois B.F.D., et al. Antiepileptic drugs: best practice guidelines for therapeutic drug monitoring-a position paper by the Subcommission on Therapeutic Drug Monitoring, ILAE Commission on Therapeutic Strategies. Epilepsia 2008, 49:1239-1276.
    • (2008) Epilepsia , vol.49 , pp. 1239-1276
    • Patsalos, P.N.1    Berry, D.J.2    Bourgeois, B.F.D.3
  • 8
    • 0036214102 scopus 로고    scopus 로고
    • Topiramate enhances the risk of valproate-associated side effects in three children
    • Longin E., Teich M., Koelfen W., König S. Topiramate enhances the risk of valproate-associated side effects in three children. Epilepsia 2002, 43:451-454.
    • (2002) Epilepsia , vol.43 , pp. 451-454
    • Longin, E.1    Teich, M.2    Koelfen, W.3    König, S.4
  • 9
    • 16844379490 scopus 로고    scopus 로고
    • Topiramate-valproate-induced hyperammonemic encephalopathy syndrome: case report
    • Cheung E., Wong V., Fung C.W. Topiramate-valproate-induced hyperammonemic encephalopathy syndrome: case report. J Child Neurol 2005, 20:157-160.
    • (2005) J Child Neurol , vol.20 , pp. 157-160
    • Cheung, E.1    Wong, V.2    Fung, C.W.3
  • 10
    • 74249120628 scopus 로고    scopus 로고
    • Valproate-induced hyperammonemic encephalopathy and normal liver functions: possible synergism with topiramate
    • Deutsch S.I., Burket J.A., Rosse R.B. Valproate-induced hyperammonemic encephalopathy and normal liver functions: possible synergism with topiramate. Clin Neuropharmacol 2009, 32:350-352.
    • (2009) Clin Neuropharmacol , vol.32 , pp. 350-352
    • Deutsch, S.I.1    Burket, J.A.2    Rosse, R.B.3
  • 11
    • 77954226162 scopus 로고    scopus 로고
    • Valproate-induced hyperammonemic encephalopathy enhanced by topiramate and phenobarbitone: a case report and an update
    • Vivekanandan S., Dinesh Nayak S. Valproate-induced hyperammonemic encephalopathy enhanced by topiramate and phenobarbitone: a case report and an update. Ann Indian Acad Neurol 2010, 13:145-147.
    • (2010) Ann Indian Acad Neurol , vol.13 , pp. 145-147
    • Vivekanandan, S.1    Dinesh Nayak, S.2
  • 12
    • 0023838892 scopus 로고
    • Hepatic and renal contributions to valproic acid-induced hyperammonemia
    • Marini A.M., Zaret B.S., Beckner R.R. Hepatic and renal contributions to valproic acid-induced hyperammonemia. Neurology 1988, 33:365-371.
    • (1988) Neurology , vol.33 , pp. 365-371
    • Marini, A.M.1    Zaret, B.S.2    Beckner, R.R.3
  • 14
    • 0020616408 scopus 로고
    • The renal origin of sodium valproate-induced hyperammonemia in fasting humans
    • Warter J.M., Brandt C., Marescaux C., et al. The renal origin of sodium valproate-induced hyperammonemia in fasting humans. Neurology 1983, 33:1136-1140.
    • (1983) Neurology , vol.33 , pp. 1136-1140
    • Warter, J.M.1    Brandt, C.2    Marescaux, C.3
  • 15
    • 0022466835 scopus 로고
    • Liver carbonic anhydrase and urea synthesis: the effect of diuretics
    • Häusinger D., Kaiser S., Stehle T., Gerok W. Liver carbonic anhydrase and urea synthesis: the effect of diuretics. Biochem Phamacol 1986, 35:3317-3322.
    • (1986) Biochem Phamacol , vol.35 , pp. 3317-3322
    • Häusinger, D.1    Kaiser, S.2    Stehle, T.3    Gerok, W.4
  • 16
    • 0032939556 scopus 로고    scopus 로고
    • Effects of anti-epileptic drugs on glutamine synthetase activity in mouse brain
    • Fraser C.M., Sills G.J., Forrest G., Thompson G.G., Brodie M.J. Effects of anti-epileptic drugs on glutamine synthetase activity in mouse brain. Br J Pharmacol 1999, 126:1634-1638.
    • (1999) Br J Pharmacol , vol.126 , pp. 1634-1638
    • Fraser, C.M.1    Sills, G.J.2    Forrest, G.3    Thompson, G.G.4    Brodie, M.J.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.